confinis is proud to announce the opening of a US branch in the Washington DC area. Starting on 1 April, 2018, Charles H. Cathlin, formerly with the US FDA and the Veterans Brain Injury Center, will lead the office and begin another chapter in the successful history of confinis. The US team will assist our current and future clients in the combination product, medical device and IVD space. The core focus and competence will be around European based clients who wish to market their products in the US. Equally, we will offer US companies the option to place their products on the European market. In addition, confinis will build out its service offering to US companies with requirements in the US.

“Since meeting Charles the first time, I have admired his passion, dedication, work ethic, personality and last but not least his humor” said confinis’ founder and CEO Beat U. Steffen. “Charles brings to confinis a unique combination of experience and expertise which I’m sure our clients will highly appreciate. I’m thrilled to have Charles onboard to build the business into the future.”

“Life should be about exploring possibilities. The prospect of joining confinis raised so many that it was impossible to resist being a part of a true powerhouse” said Cathlin. “I look forward to bringing my experience and expertise to shape its future as its next chapter opens.”

After 13+ years in the business, this is an exciting leap forward. A big “thank you” to our team for their passion and dedication, as well as to our clients and partners for their trust in us!